HPV Vaccination and Cancer Prevention Essay
HPV Vaccination and Cancer Prevention
Most of the cancer deaths worldwide are caused by cervical cancer. A limited subset of the human papillomaviruses (HPVs) is known to contribute in some manner to which infections occur (Levine, Kaper, Rappuoli, & Good, 2004). Acquisition of this infection is the most common in the United States among all other sexually transmitted diseases or STDs. Adults and sexually active adolescents are the most common victim, causing them to have genital warts as well. Due to this alarming situation, efforts have been made to formulate vaccines that would prevent its proliferation. In 2006, Food and Drugs Agency authorized the first vaccine Gardasil, a recombinant vaccine that was marketed by Merck and Co. This vaccine has a preventive action, instead of a therapeutic one, and is recommended for administration to women at the age between 19 and 25. The purpose of the vaccine is to immunize women before any sexual activity. It offers no protection to women who have already been infected. The administration is the vaccine occurs three times within a six-month period, which demonstrated 100% protection against the HPV originated cervical cancer and genital warts effected by HPV types in the vaccine (Finkel, 2007, p. 184).